Your browser doesn't support javascript.
loading
VISA-Daptomycin non-susceptible Staphylococcus aureus frequently demonstrate non-susceptibility to Telavancin.
Saravolatz, Louis D; Pawlak, Joan.
Afiliação
  • Saravolatz LD; Ascension-St. John Hospital, Detroit, MI, USA. Electronic address: louis.saravolatz@stjohn.org.
  • Pawlak J; Ascension-St. John Hospital, Detroit, MI, USA.
Diagn Microbiol Infect Dis ; 93(2): 159-161, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30366652
Telavancin was evaluated against S. aureus isolates with reduced susceptibility to other antimicrobial agents using two broth microdilution methods and Etest® strips. The three methods provided comparable results. Differences in telavancin susceptibility versus non-susceptibility were noted mainly in the VISA-daptomycin non-susceptible group of isolates. In this group the percent susceptibility was 38% for the Etest® method and 50% and 54% for the 2 broth microdilution methods. All differences in susceptibility were within one 2-fold dilution.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Staphylococcus aureus / Daptomicina / Lipoglicopeptídeos / Aminoglicosídeos / Antibacterianos Limite: Humans Idioma: En Revista: Diagn Microbiol Infect Dis Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Staphylococcus aureus / Daptomicina / Lipoglicopeptídeos / Aminoglicosídeos / Antibacterianos Limite: Humans Idioma: En Revista: Diagn Microbiol Infect Dis Ano de publicação: 2019 Tipo de documento: Article